Elicera Therapeutics AB
F:8E8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
C
|
CNX Resources Corp
XBER:CGD
|
US |
|
A
|
ACS Actividades de Construccion y Servicios SA
XMUN:OCI1
|
ES |
|
C
|
Capacite Infraprojects Ltd
NSE:CAPACITE
|
IN |
|
Agro Tech Foods Ltd
NSE:ATFL
|
IN |
|
E
|
Eurogroup Laminations SpA
MIL:EGLA
|
IT |
|
B Riley Financial Inc
NASDAQ:RILY
|
US |
|
Z
|
Zip Co Ltd
ASX:ZIP
|
AU |
|
Energous Corp
NASDAQ:WATT
|
US |
|
Quanterix Corp
NASDAQ:QTRX
|
US |
|
Ryder System Inc
NYSE:R
|
US |
|
Aeterna Zentaris Inc
TSX:AEZS
|
US |
|
P
|
Poste Italiane SpA
SWB:7PI
|
IT |
Shareholder Yield
Current shareholder yield for Elicera Therapeutics AB is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Elicera Therapeutics AB
| Average Annual Return | -17.14% |
| Standard Deviation of Annual Returns | 45.84% |
| Max Drawdown | -94% |
| Market Capitalization | 184.9m EUR |
| Shares Outstanding | 35 093 300 |
| Percentage of Shares Shorted |
N/A
|
